The biggest structural change in 45 years to the health-care sector is creating opportunities in pharmaceutical stocks while pressuring health-care providers, says Highland's Michael Gregory. Mallory Horejs: My name is…
Read More
Not even a spectacular 11th-hour rally could get stock-market funds back up into the air in the second quarter. U.S. diversified equity funds dropped 0.35% in the three months, topping…
Read More
TheStreet.com Ratings initiated coverage of 27 stock mutual funds that accrued a sufficient track record of risk and performance data by the end of May 2011. Only two of these newly rated…
Read More
The Rising Stars of Mutual Funds are chosen annually by the publishers of Institutional Investor News and represent up-and-comers whose accomplishments in and contributions to the industry make them standout among their…
Read More
The fast start for U.S. health insurer shares this year may turn into a long climb. Shunned like pariahs during the economic crisis and healthcare reform debate, the stocks have caught fire,…
Read More
Nadia Papagiannis: Hello. My name is Nadia Papagiannis, Alternative Investment Strategist here at Morningstar. Today, I have with me Jonathan Lamensdorf, Portfolio Manager of the Highland Long/Short Equity Fund, ticker…
Read More
This love affair had to cool down, even if it's just a momentary lull. Assets in U.S. diversified stock funds rebounded to $3.4 trillion from $2.99 trillion during 2010, and…
Read More